Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02454543Active, not recruiting
Randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by Martini-Klinik. Primary endpoint: Cancer specific survival at 10 years. Started May 2015; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02454543.